QUOTE AND NEWS
Forbes  May 27  Comment 
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in HanesBrands Inc (NYSE: HBI), where a total volume of 20,828 contracts has been traded thus far today, a contract volume which is...
Benzinga  May 24  Comment 
Eli Lilly and Co (NYSE: LLY) detailed in a presentation to the investment community its outlook for new product launches through 2023. Eli Lilly said that it has the potential to launch a total of 20 new products in the 10-year period beginning...
FierceBiotech  May 24  Comment 
Can Eli Lilly’s R&D game plan deliver a bottom-line rebound? john_carroll Tue, 05/24/2016 - 09:25
Benzinga  May 23  Comment 
H.C. Wainwright & Co.'s Carol Ann Werther initiated Radius Health Inc (NASDAQ: RDUS) at Buy with a $55.00 price target. The company's lead product candidate is abaloparatide (ABL), which is currently under review in Europe and the United States....
FierceBiotech  May 23  Comment 
Abemaciclib data highlight Eli Lilly’s case on CDK 4/6 john_carroll Mon, 05/23/2016 - 00:01
Benzinga  May 17  Comment 
Shares of Eli Lilly and Co (NYSE: LLY) have lost almost 10 percent since the beginning of the year. However, they have managed to recuperate almost 10 percent since their mid-March lows. Related Link: Here's How Crowdsourced Ratings Can Beat...
FiercePharma  May 11  Comment 
FDA warns of potentially fatal skin reactions to Lilly's Zyprexa ewasserman Wed, 05/11/2016 - 08:45
MedPage Today  May 10  Comment 
(MedPage Today) -- Zyprexa and Symbyax among products to get warning label
FierceBiotech  May 5  Comment 
FDA grants Eli Lilly a priority review for soft tissue sarcoma drug badams Thu, 05/05/2016 - 06:24




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki